Comparison of Indirect Calorimetry by Q-NRG With Deltatrac II
NCT ID: NCT05008757
Last Updated: 2023-06-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
60 participants
OBSERVATIONAL
2021-08-31
2023-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Values of Dose Reduction Techniques in Computed Tomography (CT) Coronary Artery Imaging With 64-row Multi-Slice Helical CT
NCT01060657
Computed Tomography Coronary Angiography (CTCA) and Coronary Flow in Stenosis Analysis
NCT00921440
Interest of the SPECT-CT Scan SUVspect in the New Generation of Gamma-cameras With Semiconductor
NCT03414021
Fractional Flow Reserve Derived From Computed Tomography Coronary Angiography in the Assessment and Management of Stable Chest Pain
NCT03187639
Comparison of Contrast Agent Administration Protocols
NCT04300972
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Q-NRG is a new device. It is relevant to compare its results with the blog standard calorimeter, the Deltratrac II.
The study will include sports healthy subjects. The could benefit from the determination of their resting energy expenditure in order to adapt their nutritional intakes.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
no drug
no intervention
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* sport practice \> 1h per day at moderate intensity
Exclusion Criteria
* unable to give a consent
18 Years
40 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Liege
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Anne-Françoise Rousseau
Head of Clinic
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Anne-Françoise Rousseau, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
University Hospital of Liège, Belgium
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Marjorie Fadeur
Liège, , Belgium
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
B7072021000024
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.